The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Tobacco firm Philip Morris seals deal for UK's Vectura with 75% support

Thu, 16th Sep 2021 07:33

* Holders of roughly 75% Vectura shares tender support

* PMI needed 50% backing for deal to go through

* Extends deadline for other holders to tender shares by
Sept. 30
(Adds detail, background)

By Pushkala Aripaka

Sept 16 (Reuters) - Cigarette maker Philip Morris (PMI)
has clinched the roughly 1-billion-pound takeover of
inhaler maker Vectura after winning the backing of about
75% of shareholders in the British company, part of its
expansion beyond tobacco.

Vectura shareholders had until Sept. 15 to decide whether to
support the 165 pence-per-share bid from PMI, which sought to
buy the London-listed asthma drug maker as part of its plan to
go "smoke-free" and switch to healthcare and wellness products.

"We have reached an important milestone in our acquisition
of Vectura and are pleased to have secured over 74% of the
company's shares, in excess of the 50% required to make our
offer unconditional and PMI the majority shareholder," PMI Chief
Executive Jacek Olczak said in a statement on Thursday.

PMI had received the shares from shareholders through a
public tender offer process, and the cigarette maker's offer for
Vectura cannot be withdrawn now.

PMI, which fought off private equity firm Carlyle Group
for the buyout of Vectura, had switched its proposal to a
takeover offer from a so-called scheme of arrangement to raise
its chances.

The switch allowed PMI to require the support of holders of
just over 50% of Vectura shares for the deal to go through.

Philip Morris has received regulatory clearances for the
deal and had won the backing of Vectura's board, but health
groups are questioning the idea of a tobacco company making
money from treating the very illnesses that cigarettes cause.

Olczak said PMI would provide Vectura's scientists with the
resources and expertise to reach a target of at least $1 billion
in net revenue from its "Beyond Nicotine" products by 2025.

The U.S.-based company has also extended the deadline for
the remaining Vectura shareholders to tender their shares to
Sept. 30.

($1 = 0.7234 pounds)
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Devika
Syamnath and Emelia Sithole-Matarise)

More News
26 May 2021 11:32

LIVE MARKETS-U.S. stock valuations face headwinds

* European shares erase gains* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thoms...

Read more
26 May 2021 11:15

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

TOP NEWS: Carlyle offers GBP958 million for asthma drug maker Vectura

Read more
26 May 2021 11:06

LIVE MARKETS-Equities: another choppy summer?

* European shares up 0.1%* Fed soothes inflation fears* U.S. equity futures upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters...

Read more
26 May 2021 10:04

LIVE MARKETS-Who is paying dividends

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 09:33

LIVE MARKETS-M&S: a tricky morning call

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 09:18

UPDATE 2- British midcaps rise on strong earnings, Vectura shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Vectura surges on agreeing to $1.4 bln takeover by Carlyle* Marks & Spencer rises on positive profit outlook* Croda rises on double upgrade...

Read more
26 May 2021 08:47

LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A

LONDON MARKET OPEN: Vectura and Mediclinic boost FTSE 250 amid M&A

Read more
26 May 2021 08:44

LIVE MARKETS-STOXX below peak, banks dip, some M&A action

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 08:44

LIVE MARKETS-STOXX below peak, banks dip, some M&A action

* European shares up 0.2%* Fed soothes inflation fears* U.S. equity futures edge upMay 26 - Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonre...

Read more
26 May 2021 07:57

LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers

LONDON MARKET PRE-OPEN: Vectura and Spire Healthcare accept offers

Read more
26 May 2021 07:56

Vectura to be taken over by Carlyle in £958m deal

(Sharecast News) - Pharmaceutical company Vectura said on Wednesday that it has agreed to be taken over by US private equity firm The Carlyle Group in a £958m deal, sending the shares sharply higher.

Read more
26 May 2021 07:38

UPDATE 1-UK pharma group Vectura agrees $1.4 bln takeover by Carlyle

(Adds details)LONDON, May 26 (Reuters) - Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group.Shareho...

Read more
26 May 2021 07:12

Vectura agrees 958 mln stg takeover by The Carlyle Group

LONDON, May 26 (Reuters) - Vectura Group, a British pharmaceutical company focused on inhaled medicines, said on Wednesday it had agreed a 958 million pound ($1.36 billion) takeover by global investment firm The Carlyle Group. ($1 = 0.7067 pounds...

Read more
20 May 2021 16:07

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Apr 2021 10:06

Hikma resumes asthma drug launch, Vectura pays special dividend

Hikma resumes asthma drug launch, Vectura pays special dividend

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.